Patients with relapsed/refractory multiple myeloma could benefit from repeat treatment with drugs their disease has ...

Discover a trial in which patients received either IL-2 or a placebo for 5 days, followed by weekly doses for 4 weeks.

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...

NOVEL molecular regulators of rheumatoid arthritis (RA) inflammation were presented as part of a plenary abstract session at ...

PATIENTS with traumatic brain injury (TBI) and hypotension have a significantly increased risk of mortality, underscoring the importance of precise blood pressure management in clinical settings.

CAR T-cell therapy shows promise for solid tumors like glioblastoma. New engineering strategies and clinical trial results ...

Revisto has raised $4m in seed funding to simplify the pharmaceutical industry's marketing compliance processes using AI.

No significant difference found between hydrocortisone replacement and prednisone tapering for glucocorticoid discontinuation ...

A new report reveals high rates of preventable pregnancy-related cardiovascular deaths, underscoring racial disparities and ...

PORTAL vein thrombosis (PVT) is a common and serious complication in patients with liver cirrhosis. It can lead to obstructed ...

A recent systematic review and meta-analysis reveals dermatologists have a significantly higher accuracy in diagnosing skin ...

A recent study explores how MYCN-driven neuroblastoma hijacks the m6A modification process to prevent proper cell ...